TATAA Biocenter Becomes Certified Service Provider for HTG Molecular Diagnostics

TATAA Biocenter, a leading provider of high-quality molecular analysis services, has announced that it has become a certified Qualified Service Provider for HTG Molecular Diagnostics. This certification allows TATAA to offer high-throughput, multiplex gene expression profiling to its customers, expanding its portfolio of molecular analysis services.

Certification Brings Advanced Technology for Gene Expression Profiling

HTG Molecular Diagnostics is a life science company that advances precision medicine through innovative transcriptome-wide profiling technology, HTG EdgeSeq™. This technology analyzes gene expression in large numbers of genes simultaneously, making it useful for complex gene expression profile research, such as in oncology, immunology, and neurology. The HTG EdgeSeq technology does not require RNA extraction, and can use small amounts of tissue material, typically several mm2, to generate reproducible gene expression profiles.

TATAA’s Founder and CEO, Mikael Kubista, said, “We are excited to be a certified qualified service provider for HTG technology. Our team of scientists has been extensively trained in this technology, and we are well-equipped to provide our customers with the highest-quality service for high-throughput, multiplex gene expression profiling.”

Partnership Thrives on Dedication to Excellence

Selina Gaertner, Director, EU Medical Affairs at HTG Molecular Diagnostics, said, “Your commitment to excellence and dedication to providing a top-notch service has been truly inspiring, and we are thrilled to have you as a partner.”

Jean Claude Gerard, Vice President, Global Sales, HTG Molecular Diagnostics, stated, “We are really pleased to count TATAA Biocenter among our limited number of Qualified Service Providers. They represent the perfect service we need to recommend to our end-users, running our technology with high standards and professionalism.”

Comprehensive Solutions for Gene Expression Profiling and Biomarker Discovery

Jens Björkman, COO, TATAA Biocenter, added, “This certification reflects our commitment to providing our customers with the most advanced genomic services available. With HTG EdgeSeq technology, we can now offer even more comprehensive solutions for gene expression profiling and biomarker discovery.”

TATAA Biocenter is a pioneer in qPCR, digital PCR, and Next-Generation Sequencing (NGS) services and products, serving customers in academia, industry, and healthcare. This certification further expands its portfolio of advanced molecular biology technologies, providing clients with the most innovative and reliable solutions for their research and clinical needs.

Conclusion

TATAA Biocenter’s certification as a Qualified Service Provider for HTG Molecular Diagnostics allows it to offer more comprehensive solutions for gene expression profiling and biomarker discovery. With this technology, TATAA is poised to continue expanding its portfolio of advanced molecular biology technologies, providing clients with the most innovative and reliable solutions for their research and clinical needs.